Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,106 public trials 2,040 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Open Label Study to Evaluate the Safety and Efficacy of Lenalidomide With MOR00208 in Patients With R-R DLBCL

NCT02399085

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • CBCC Global Research, Inc. at Comprehensive Blood and Cancer Center Bakersfield, California, United States
  • UCLA - David Geffen School of Medicine Los Angeles, California, United States
  • Cancer Care - Torrance Memorial Physician Network Redondo Beach, California, United States
  • Central Coast Medical Oncology Corporation Santa Maria, California, United States
View all 57 locations
View Trial Details
Completed

A Study of the Safety and Efficacy of Venetoclax in Japanese Participants With Relapsed and Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Leukemia)

NCT04198415

Conditions
Cancer, Chronic Disease, Chronic Lymphocytic Leukemia (CLL), +17 more
Locations
  • Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital /ID# 239524 Nagoya, Aichi-ken, Japan
  • Nagoya University Hospital /ID# 225300 Nagoya, Aichi-ken, Japan
  • Nagoya City University Hospital /ID# 240820 Nagoya, Aichi-ken, Japan
  • Toyohashi Municipal Hospital /ID# 227433 Toyohashi, Aichi-ken, Japan
View all 102 locations
View Trial Details
Completed

Real-World Clinical Outcomes in Adult Patients Who Initiate Systemic Treatment for Relapsed/Refractory Diffuse Large B-Cell Lymphoma

NCT05338892

Conditions
Chronic Disease, Diffuse Large B-cell Lymphoma, Disease Attributes, +20 more
Locations
  • Regeneron Research Facility Graz, Austria
  • Regeneron Research Facility Caen, France
  • Regeneron Research Facility Paris, France
  • Regeneron Research Facility Pierre-Bénite, France
View Trial Details
Completed

Study to Evaluate t(11;14) Status and BCL2 Expression in Adult Participants With Multiple Myeloma (MM)

NCT04721002

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations
  • Tulane School of Medicine /ID# 223864 New Orleans, Louisiana, United States
  • University of Texas Southwestern Medical Center /ID# 223865 Dallas, Texas, United States
  • Hospital Italiano de Buenos Aires /ID# 224153 Ciudad Autonoma Buenos Aires, Buenos Aires F.D., Argentina
  • Alfred Health /ID# 224386 Melbourne, Victoria, Australia
View all 40 locations
View Trial Details
Completed

Real-World Clinical Outcomes in Adult Patients Who Initiate Systemic Treatment for Relapsed or Refractory Follicular Lymphoma

NCT05338879

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations
  • Regeneron Research Facility Graz, Austria
  • Regeneron Research Facility Caen, France
  • Regeneron Research Facility Paris, France
  • Regeneron Research Facility Pierre-Bénite, France
View Trial Details

Related conditions